IMMUTEP LIMITED — Director's Dealing 2010

Dec 9, 2010

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

	PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
ABN:	90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Dr. Neil Frazer Date of Last Notice: 27 July 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest		Direct	Direct
Nature of Indirect Interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		-
Date of change		6 December 2010
No. of securities held prior to change				Options - - -
			Shares	Options
		Direct	-	-
		Indirect	-	-
		Total	-	-
Class		Unlisted Options
Number Acquired
			Shares	Options
		Direct	-	2,000,000
		Indirect	-	-
		Total	-	2,000,000

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number Disposed				Options - - -
			Shares	Options
		Direct	-	-
		Indirect	-	-
		Total	-	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Nil
No. of Securities Held After Change				Options 2,000,000 - 2,000,000
			Shares	Options
		Direct	-	2,000,000
		Indirect	-	-
		Total	-	2,000,000
Nature of Change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issuance of Directors’ Options as approved at the 2010 AGM held on 26 November 2010.

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest	Employment Contract
Name of Registered Holder (if issued securities)	Dr. Neil Frazer
Date of Change	6 December 2010
No. and Class of Securities to Which Interest Related Prior to Change Note: Details are only required for a contract in relation to which the interest has changed	-
Interest Acquired	-
Interest Disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	Employment as per employee services contract
Interest After Change	-

==> picture [50 x 29] intentionally omitted <==

The CFO Solution

10.12.2010

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

	PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
ABN:	90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Mr Martin Rogers Date of Last Notice: 27 July 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest		Indirect	Indirect
Nature of Indirect Interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Director related entity
Date of change		6 December 2010
No. of securities held prior to change				Options - 12,345,238 12,345,238
			Shares	Options
		Direct	-	-
		Indirect	20,821,500	12,345,238
		Total	20,821,500	12,345,238
Class		Directors Options
Number Acquired				Options - 10,000,000 10,000,000
			Shares	Options
		Direct	-	-
		Indirect	-	10,000,000
		Total	-	10,000,000

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number Disposed				Options - - -
			Shares	Options
		Direct	-	-
		Indirect	-	-
		Total	-	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Director Services
No. of Securities Held After Change				Options - 22,345,238 22,345,238
			Shares	Options
		Direct	-	-
		Indirect	20,821,500	22,345,238
		Total	20,821,500	22,345,238
Nature of Change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issuance of Directors’ Options as approved at the 2010 AGM held on 26 November 2010

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest
Name of Registered Holder (if issued securities)
Date of Change
No. and Class of Securities to Which Interest Related Prior to Change Note: Details are only required for a contract in relation to which the interest has changed
Interest Acquired
Interest Disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest After Change

==> picture [50 x 30] intentionally omitted <==

The CFO Solution

10.12.2010

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

	PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
ABN:	90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Ms Lucy Turnbull Date of Last Notice: 7 October 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest		Direct	Direct
Nature of Indirect Interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		N/A
Date of change		6 December 2010
No. of securities held prior to change				Options - - -
			Shares	Options
		Direct	4,347,076	-
		Indirect	-	-
		Total	4,347,076	-
Class		Directors’Options
Number Acquired				Options 10,000,000 - 10,000,000
			Shares	Options
		Direct	-	10,000,000
		Indirect	-	-
		Total	-	10,000,000

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number Disposed				Options - - -
			Shares	Options
		Direct	-	-
		Indirect	-	-
		Total	-	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Director Services
No. of Securities Held After Change				Options 10,000,000 - 10,000,000
			Shares	Options
		Direct	4,347,076	10,000,000
		Indirect	-	-
		Total	4,347,076	10,000,000
Nature of Change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issuance of Directors’ Options as approved at the 2010 AGM held on 26 November 2010

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest
Name of Registered Holder (if issued securities)
Date of Change
No. and Class of Securities to Which Interest Related Prior to Change Note: Details are only required for a contract in relation to which the interest has changed
Interest Acquired
Interest Disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest After Change

==> picture [50 x 29] intentionally omitted <==

The CFO Solution 10.12.2010

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

	PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
ABN:	90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Mr Albert Wong Date of Last Notice: 11 August 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest		Indirect	Indirect	Indirect
Nature of Indirect Interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Director related entity
Date of change		6 December 2010
No. of securities held prior to change		Shares Options Direct - - Indirect 2,000,000 - Total 2,000,000 -
Class		Fully Paid Ordinary Shares and Directors Options
Number Acquired				Options - 7,500,000 7,500,000
			Shares	Options
		Direct	-	-
		Indirect	1,250,000	7,500,000
		Total	1,250,000	7,500,000

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number Disposed				Options - - -
			Shares	Options
		Direct	-	-
		Indirect	-	-
		Total	-	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Director Services
No. of Securities Held After Change				Options - 7,500,000 7,500,000
			Shares	Options
		Direct	-	-
		Indirect	3,250,000	7,500,000
		Total	3,250,000	7,500,000
Nature of Change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issuance of equities as approved at the 2010 AGM held on 26 November 2010

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest
Name of Registered Holder (if issued securities)
Date of Change
No. and Class of Securities to Which Interest Related Prior to Change Note: Details are only required for a contract in relation to which the interest has changed
Interest Acquired
Interest Disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest After Change

==> picture [50 x 30] intentionally omitted <==

The CFO Solution

10.12.2010

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: PRIMA BIOMED LIMITED (ASX: PRR) ABN: 90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: DR. RICHARD HAMMEL Date of Last Notice: 17 September 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [395 x 239] intentionally omitted <==

----- Start of picture text -----

Direct or Indirect Interest Indirect
Nature of Indirect Interest
(including registered holder) Director Related Entity
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change 6 December 2010
No. of securities held prior to change
Shares Options
Direct - -
Indirect 5,000,000 7,619,047
Total 5,000,000 7,619,047
Class Directors Options
Number Acquired Shares Options
Direct - -
Indirect - 5,000,000
Total - 5,000,000
----- End of picture text -----

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number Disposed			Shares	Options
		Direct	-	-
		Indirect	-	-
		Total	-	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Director Services
No. of Securities Held After Change				Options - 12,619,047 12,619,047
			Shares	Options
		Direct	-	-
		Indirect	5,000,000	12,619,047
		Total	5,000,000	12,619,047
Nature of Change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issuance of Directors Options as approved at the 2010 AGM held on 26 November 2010

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest
Name of Registered Holder (if issued securities)
Date of Change
No. and Class of Securities to Which Interest Related Prior to Change Note: Details are only required for a contract in relation to which the interest has changed
Interest Acquired
Interest Disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest After Change

==> picture [23 x 13] intentionally omitted <==

The CFO Solution

10.12.2010

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002